|
1
|
Krieger N, Bassett MT and Gomez SL: Breast
and cervical cancer in 187 countries between 1980 and 2010. Lancet.
379:2990–1392. 2012. View Article : Google Scholar
|
|
2
|
Bosch FX and de Sanjosé S: The
epidemiology of human papillomavirus infection and cervical cancer.
Dis Markers. 23:213–227. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bosch FX, Lorincz A, Muñoz N, Meijer CJ
and Shah KV: The causal relation between human papillomavirus and
cervical cancer. J Clin Pathol. 55:244–265. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Franco EL, Duarte-Franco E and Ferenczy A:
Cervical cancer: Epidemiology, prevention and the role of human
papillomavirus infection. CMAJ. 164:1017–1025. 2001.PubMed/NCBI
|
|
5
|
Dizon DS, Mackay HJ, Thomas GM, Werner TL,
Kohn EC, Hess D, Rose PG and Covens AL: State of the science in
cervical cancer: Where we are today and where we need to go.
Cancer. 120:2282–2288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu K, He Y, Xia C, Yan J, Hou J, Kong D,
Yang Y and Zheng G: MicroRNA-15a inhibits proliferation and induces
apoptosis in CNE1 nasopharyngeal carcinoma cells. Oncol Res.
24:145–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou Y, Yang C, Wang K, Liu X and Liu Q:
MicroRNA-33b inhibits the proliferation and migration of
osteosarcoma cells via targeting hypoxia-inducible factor-1α. Oncol
Res. 25:397–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang S, Hui Y, Li X and Jia Q: Silencing
of lncRNA CCDC26 restrains the growth and migration of glioma cells
in vitro and in vivo via targeting miR-203. Oncol
Res. 26:1143–1154. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Zhou Q, Tao L and Yu C:
MicroRNA-106a promotes cell migration and invasion by targeting
tissue inhibitor of matrix metalloproteinase 2 in cervical cancer.
Oncol Rep. 38:1774–1782. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qian B, Zhao L, Wang X, Xu J, Teng F, Gao
L and Shen R: RETRACTED: miR-149 regulates the proliferation and
apoptosis of cervical cancer cells by targeting GIT1. Biomed
Pharmacother. 105:1106–1116. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang HD, Jiang LH, Sun DW, Jian L and Ji
ZL: The role of miR-130a in cancer. Breast Cancer. 24:521–527.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kong X, Zhang J, Li J, Shao J and Fang L:
MiR-130a-3p inhibits migration and invasion by regulating RAB5B in
human breast cancer stem cell-like cells. Biochem Biophys Res
Commun. 501:486–493. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y, Li Y, Wang R, Qin S, Liu J, Su F,
Yang Y, Zhao F, Wang Z and Wu Q: MiR-130a-3p regulates cell
migration and invasion via inhibition of Smad4 in gemcitabine
resistant hepatoma cells. J Exp Clin Cancer Res. 35:192016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Subramaniam MM, Chan JY, Yeoh KG, Quek T,
Ito K and Salto-Tellez M: Molecular pathology of RUNX3 in human
carcinogenesis. Biochim Biophys Acta. 1796:315–331. 2009.PubMed/NCBI
|
|
15
|
Huang B, Qu Z, Ong CW, Tsang YH, Xiao G,
Shapiro D, Salto-Tellez M, Ito K, Ito Y and Chen LF: RUNX3 acts as
a tumor suppressor in breast cancer by targeting estrogen receptor
α. Oncogene. 31:527–534. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nishina S, Shiraha H, Nakanishi Y, Tanaka
S, Matsubara M, Takaoka N, Uemura M, Horiguchi S, Kataoka J,
Iwamuro M, et al: Restored expression of the tumor suppressor gene
RUNX3 reduces cancer stem cells in hepatocellular carcinoma by
suppressing Jagged1-Notch signaling. Oncol Rep. 26:523–531.
2011.PubMed/NCBI
|
|
17
|
Voon DC, Wang H, Koo JK, Nguyen TA, Hor
YT, Chu YS, Ito K, Fukamachi H, Chan SL, Thiery JP and Ito Y: Runx3
protects gastric epithelial cells against epithelial-mesenchymal
transition-induced cellular plasticity and tumorigenicity. Stem
Cells. 30:2088–2099. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Egawa H, Jingushi K, Hirono T, Ueda Y,
Kitae K, Nakata W, Fujita K, Uemura M, Nonomura N and Tsujikawa K:
The miR-130 family promotes cell migration and invasion in bladder
cancer through FAK and Akt phosphorylation by regulating PTEN. Sci
Rep. 6:205742016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sakakura C, Hasegawa K, Miyagawa K,
Nakashima S, Yoshikawa T, Kin S, Nakase Y, Yazumi S, Yamagishi H,
Okanoue T, et al: Possible involvement of RUNX3 silencing in the
peritoneal metastases of gastric cancers. Clin Cancer Res.
11:6479–6488. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yano T, Ito K, Fukamachi H, Chi XZ, Wee
HJ, Inoue K, Ida H, Bouillet P, Strasser A, Bae SC and Ito Y: The
RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells
undergoing transforming growth factor beta-induced apoptosis. Mol
Cell Biol. 26:4474–4488. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Z, Fan P, Deng M and Zeng C: The roles
of RUNX3 in cervical cancer cells in vitro. Oncol Lett.
15:8729–8734. 2018.PubMed/NCBI
|
|
22
|
Takeshima N, Yanoh K, Tabata T, Nagai K,
Hirai Y and Hasumi K: Assessment of the revised international
federation of gynecology and obstetrics staging for early invasive
squamous cervical cancer. Gynecol Oncol. 74:165–169. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yao T and Lin Z: MiR-21 is involved in
cervical squamous cell tumorigenesis and regulates CCL20. Biochim
Biophys Acta. 1822:248–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Long MJ, Wu FX, Li P, Liu M, Li X and Tang
H: MicroRNA-10a targets CHL1 and promotes cell growth, migration
and invasion in human cervical cancer cells. Cancer Lett.
324:186–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qin W, Dong P, Ma C, Mitchelson K, Deng T,
Zhang L, Sun Y, Feng X, Ding Y, Lu X, et al: MicroRNA-133b is a key
promoter of cervical carcinoma development through the activation
of the ERK and AKT1 pathways. Oncogene. 31:4067–4075. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen W, Tong K and Yu J: MicroRNA-130a is
upregulated in colorectal cancer and promotes cell growth and
motility by directly targeting forkhead box F2. Mol Med Rep.
16:5241–5248. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yin S, Zhang Q, Wang Y, Li S and Hu R:
MicroRNA-130a regulated by HPV18 E6 promotes proliferation and
invasion of cervical cancer cells by targeting TIMP2. Exp Ther Med.
17:2837–2846. 2019.PubMed/NCBI
|
|
29
|
Jiang H, Yu WW, Wang LL and Peng Y:
miR-130a acts as a potential diagnostic biomarker and promotes
gastric cancer migration, invasion and proliferation by targeting
RUNX3. Oncol Rep. 34:1153–1161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen J, Yan D, Wu W, Zhu J, Ye W and Shu
Q: MicroRNA-130a promotes the metastasis and epithelial-mesenchymal
transition of osteosarcoma by targeting PTEN. Oncol Rep.
35:3285–3292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sato K, Tomizawa Y, Iijima H, Saito R,
Ishizuka T, Nakajima T and Mori M: Epigenetic inactivation of the
RUNX3 gene in lung cancer. Oncol Rep. 15:129–135. 2006.PubMed/NCBI
|
|
32
|
Zhang Z, Wang S, Wang M, Tong N, Fu G and
Zhang Z: Genetic variants in RUNX3 and risk of bladder cancer: A
haplotype-based analysis. Carcinogenesis. 29:1973–1978. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lai KW, Koh KX, Loh M, Tada K, Subramaniam
MM, Lim XY, Vaithilingam A, Salto-Tellez M, Iacopetta B, Ito Y, et
al: MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric
cancer. Eur J Cancer. 46:1456–1463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao QQ, Zhou B, Yu XZ, Zhang Z, Wang YY,
Song YP, Zhang L, Luo H and Xi MR: Transcriptome changes induced by
RUNX3 in cervical cancer cells in vitro. Oncol Lett.
19:651–662. 2010.
|
|
35
|
Cortez CC, Liang G, Van Rietschoten A, Jia
L, Tsai YC, Egger G and Jones PA: RUNX3: Promoter 1 methylation
status. Cancer Res. 66 (8 Supp):S3722006.
|
|
36
|
Kim TY, Lee HJ, Hwang KS, Lee M, Kim JW,
Bang YJ and Kang GH: Methylation of RUNX3 in various types of human
cancers and premalignant stages of gastric carcinoma. Lab Invest.
84:479–484. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Park WS, Cho YG, Kim CJ, Song JH, Lee YS,
Kim SY, Nam SW, Lee SH, Yoo NJ and Lee JY: Hypermethylation of the
RUNX3 gene in hepatocellular carcinoma. Exp Mol Med. 37:276–281.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li QL, Kim HR, Kim WJ, Choi JK, Lee YH,
Kim HM, Li LS, Kim H, Chang J, Ito Y, et al: Transcriptional
silencing of the RUNX3 gene by CpG hypermethylation is associated
with lung cancer. Biochem Biophys Res Commun. 314:223–228. 2004.
View Article : Google Scholar : PubMed/NCBI
|
